Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - SAB Biotherapeutics, Inc. | StockGist | StockGist

Companies
SABS
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings SABSSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

SAB Biotherapeutics, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001833214

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

5.10%

Reporting Person

SAB Biotherapeutics, Inc.

Person Type

PN

CUSIP: 78397T202

Amendment History

5 filings

SCHEDULE 13G
Original
Jan 22, 20260001193125-26-019535
SCHEDULE 13G/A
Amendment 1
Feb 17, 20260001493215-26-000048
SCHEDULE 13G/A
Amendment 2
Feb 17, 20260001493215-26-000048
SCHEDULE 13G/A
Amendment 3
Viewing
Feb 17, 20260000921895-26-000472
SCHEDULE 13G/A
Amendment 4
Latest
Viewing
Feb 17, 20260000921895-26-000472

Key Facts

% of Class

5.10%

Recent Filings

SAB Biotherapeutics, Inc.1 weeks ago

SAB Biotherapeutics, Inc.3 weeks ago

SAB Biotherapeutics, Inc.3 weeks ago

SAB Biotherapeutics, Inc.3 weeks ago

SAB Biotherapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice